Day One Biopharmaceuticals, Inc.
- DAWN
- NASDAQ
- Biotechnology
- Precision Oncology
- Targeted Cancer Therapies
$21.53
Quote Apr 24, 2026, 01:30 PM UTC
+0.75%over the last month
Max drawdown −0.2%From 1-month high 0.0%3 months +80.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$2.22B
Quote Apr 24
Next earnings
—
Data unavailable
Analyst target
$31.30
+45.4% from here
Floor
$21.36
0.8% below price
Where the price sits
12 analysts
Analyst range, low to high
$21.50$45.00
- Price $21.53
- Resistance $21.87–$22.09
- Consensus $31.30
The price is just above its floor and right under resistance. Analysts' average target sits about 45% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about DAWNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q4 2025 revenue $53.7M
- Product$52.8M98.4%
- License$884,0001.6%
Industry
Biotechnology
Employees
181